Jonathan Cousin


I enjoy working with my clients, from conception through commercialization of their inventions, to build a robust patent portfolio.

Jon advises pharmaceutical companies and specializes in integrating regulatory and patent exclusivity strategies in order to maximize the value of his clients’ products. He has worked on several Orange Book-listed products. He works closely with his clients to develop and implement patent strategies, with a particular focus on late-stage clinical trial inventions that provide significant additional patent protection. He also has experience conducting patentability, invalidity, freedom-to-operate/non-infringement analyses, IPOs, and due diligence for acquisitions and sales.

Download full bio 


  • Rodeo Therapeutics Agrees to Sell to Amgen for $721 Million 

  • Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million 

  • Jazz Pharmaceuticals Acquires Celator for $1.5 Billion 


  • Ohio Northern University
    JD, cum laude, 2010

  • Montana State University
    PhD, Organic Chemistry

  • University of Georgia
    BS, Environmental Resource Science

  • University of Georgia
    BS, Chemistry

Admissions & Credentials

District of Columbia

Registered to practice before the United States Patent & Trademark Office (USPTO)

Media & Insight


  • American Intellectual Property Law Association